Fusion protein technologies for biopharmaceuticals : applications and challenges /

The state of the art in biopharmaceutical FUSION PROTEIN DESIGN Fusion proteins belong to the most lucrative biotech drugs-with Enbrel® being one of the best-selling biologics worldwide. Enbrel® represents a milestone of modern therapies just as Humulin®, the first therapeutic recombinant protein fo...

Full description

Bibliographic Details

Other Authors:	Schmidt, Stefan R.
Format:	eBook
Language:	English
Published:	Hoboken, New Jersey : John Wiley & Sons, ©2013.
Subjects:	Biopharmaceutics. Pharmaceutical biotechnology. Recombinant Fusion Proteins > therapeutic use. Drug Carriers. Immunotoxins > pharmacokinetics. Immunotoxins > therapeutic use. Protein Engineering. Recombinant Fusion Proteins > pharmacokinetics. Electronic books.
Online Access:	Connect to the full text of this electronic book